Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece
Kyriakos Souliotis,1,2 Christina Golna,2 Christina Poimenidou,2 Tatiana Drakopoulou,3 Memi Tsekoura,2 Damon Willems,4 Vasileios Kountouris,5 Polyzois Makras6 1Department of Social and Education Policy, University of Peloponnese, Corinth, Greece; 2Research Department, Health Policy Institute, Marouss...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-01-01
|
| Series: | Patient Preference and Adherence |
| Subjects: | |
| Online Access: | https://www.dovepress.com/disease-burden-and-treatment-preferences-amongst-postmenopausal-women--peer-reviewed-fulltext-article-PPA |
| _version_ | 1797956570760347648 |
|---|---|
| author | Souliotis K Golna C Poimenidou C Drakopoulou T Tsekoura M Willems D Kountouris V Makras P |
| author_facet | Souliotis K Golna C Poimenidou C Drakopoulou T Tsekoura M Willems D Kountouris V Makras P |
| author_sort | Souliotis K |
| collection | DOAJ |
| description | Kyriakos Souliotis,1,2 Christina Golna,2 Christina Poimenidou,2 Tatiana Drakopoulou,3 Memi Tsekoura,2 Damon Willems,4 Vasileios Kountouris,5 Polyzois Makras6 1Department of Social and Education Policy, University of Peloponnese, Corinth, Greece; 2Research Department, Health Policy Institute, Maroussi, Greece; 3Greek Bone Health Association “Petalouda”, Perama, Greece; 4Market Access Lead, UCB Pharma, Brussels, Belgium; 5External Engagement Lead, UCB Pharma, Athens, Greece; 6Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, GreeceCorrespondence: Kyriakos Souliotis, Email info@ksouliotis.grObjective: The objectives of this study were to elicit self-reported health status, quantify osteoporosis-related burden, and understand preferences for treatment attributes among postmenopausal women with severe osteoporosis in Greece.Methods: Postmenopausal women with self-reported severe osteoporosis, defined as having suffered at least one osteoporotic fracture and reporting a T-score of ≤− 2.5, were asked to evaluate their health status, osteoporosis management, and disease-related physical, emotional, and financial burden. Participants were also asked to rate a series of treatment attributes and state their preference for unlabeled anabolic treatments, based on scenarios describing key treatment characteristics.Results: Approximately one third (31%) of the 186 participants who responded to the survey in full had been living with severe osteoporosis for more than 10 years. Three quarters of participants (72%) considered their overall quality of life (QoL) to be worse than it had been 10 years prior, and the vast majority (89%) attributed this deterioration to osteoporosis. Direct, out of pocket, disease-related costs of at least € 100 per month were reported by 86% of participants. Patients attached the greatest value to a treatment that would decrease probability of future fractures, followed by increase in bone density, safety, and mode and frequency of administration. When asked to select their preferred treatment scenario between two anabolic treatments, 70% of participants opted for the scenario that shared treatment characteristics with romosozumab over a scenario that shared treatment characteristics with teriparatide.Conclusion: Our study revealed that osteoporosis placed a considerable burden on QoL for postmenopausal women with severe osteoporosis in Greece. Patients reported valuing treatment efficacy, measured through reduction in future fractures and increase in bone density, and safety, as key treatment attributes.Keywords: osteoporosis, patient preference, burden of disease, quality of life |
| first_indexed | 2024-04-10T23:50:59Z |
| format | Article |
| id | doaj.art-1925371bad684ad08e77eb77eddeaceb |
| institution | Directory Open Access Journal |
| issn | 1177-889X |
| language | English |
| last_indexed | 2024-04-10T23:50:59Z |
| publishDate | 2023-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Patient Preference and Adherence |
| spelling | doaj.art-1925371bad684ad08e77eb77eddeaceb2023-01-10T18:24:31ZengDove Medical PressPatient Preference and Adherence1177-889X2023-01-01Volume 1710711880892Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in GreeceSouliotis KGolna CPoimenidou CDrakopoulou TTsekoura MWillems DKountouris VMakras PKyriakos Souliotis,1,2 Christina Golna,2 Christina Poimenidou,2 Tatiana Drakopoulou,3 Memi Tsekoura,2 Damon Willems,4 Vasileios Kountouris,5 Polyzois Makras6 1Department of Social and Education Policy, University of Peloponnese, Corinth, Greece; 2Research Department, Health Policy Institute, Maroussi, Greece; 3Greek Bone Health Association “Petalouda”, Perama, Greece; 4Market Access Lead, UCB Pharma, Brussels, Belgium; 5External Engagement Lead, UCB Pharma, Athens, Greece; 6Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, GreeceCorrespondence: Kyriakos Souliotis, Email info@ksouliotis.grObjective: The objectives of this study were to elicit self-reported health status, quantify osteoporosis-related burden, and understand preferences for treatment attributes among postmenopausal women with severe osteoporosis in Greece.Methods: Postmenopausal women with self-reported severe osteoporosis, defined as having suffered at least one osteoporotic fracture and reporting a T-score of ≤− 2.5, were asked to evaluate their health status, osteoporosis management, and disease-related physical, emotional, and financial burden. Participants were also asked to rate a series of treatment attributes and state their preference for unlabeled anabolic treatments, based on scenarios describing key treatment characteristics.Results: Approximately one third (31%) of the 186 participants who responded to the survey in full had been living with severe osteoporosis for more than 10 years. Three quarters of participants (72%) considered their overall quality of life (QoL) to be worse than it had been 10 years prior, and the vast majority (89%) attributed this deterioration to osteoporosis. Direct, out of pocket, disease-related costs of at least € 100 per month were reported by 86% of participants. Patients attached the greatest value to a treatment that would decrease probability of future fractures, followed by increase in bone density, safety, and mode and frequency of administration. When asked to select their preferred treatment scenario between two anabolic treatments, 70% of participants opted for the scenario that shared treatment characteristics with romosozumab over a scenario that shared treatment characteristics with teriparatide.Conclusion: Our study revealed that osteoporosis placed a considerable burden on QoL for postmenopausal women with severe osteoporosis in Greece. Patients reported valuing treatment efficacy, measured through reduction in future fractures and increase in bone density, and safety, as key treatment attributes.Keywords: osteoporosis, patient preference, burden of disease, quality of lifehttps://www.dovepress.com/disease-burden-and-treatment-preferences-amongst-postmenopausal-women--peer-reviewed-fulltext-article-PPAosteoporosispatient preferenceburden of diseasequality of life |
| spellingShingle | Souliotis K Golna C Poimenidou C Drakopoulou T Tsekoura M Willems D Kountouris V Makras P Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece Patient Preference and Adherence osteoporosis patient preference burden of disease quality of life |
| title | Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece |
| title_full | Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece |
| title_fullStr | Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece |
| title_full_unstemmed | Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece |
| title_short | Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece |
| title_sort | disease burden and treatment preferences amongst postmenopausal women with severe osteoporosis in greece |
| topic | osteoporosis patient preference burden of disease quality of life |
| url | https://www.dovepress.com/disease-burden-and-treatment-preferences-amongst-postmenopausal-women--peer-reviewed-fulltext-article-PPA |
| work_keys_str_mv | AT souliotisk diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece AT golnac diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece AT poimenidouc diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece AT drakopoulout diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece AT tsekouram diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece AT willemsd diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece AT kountourisv diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece AT makrasp diseaseburdenandtreatmentpreferencesamongstpostmenopausalwomenwithsevereosteoporosisingreece |